Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.
Dicot Pharma has raised $22.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Dicot Pharma's investors include Almi Invest.
Dicot Pharma is headquartered in Uppsala, Sweden.
Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.
Dicot Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dicot Pharma — Funding & Investors." VCBacked, June 4, 2026, https://www.vcbacked.co/company/dicot-pharma. Accessed September 30, 2026.
VCBacked. (2026). Dicot Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/dicot-pharma
{{cite web |title=Dicot Pharma — Funding & Investors |url=https://www.vcbacked.co/company/dicot-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated